PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
24-Aug-2022 Laparoscopic Devices Market is anticipated to increase from a valuation of US$ 12.3 Billion in 2022 MARKITWIRED
24-Aug-2022 Herpes Labialis Treatment Market is expected to register a CAGR of nearly 4.7% over the forecast period 2022-2028 MARKITWIRED
24-Aug-2022 Cellefill™, a new integrated solution to fast-track cell, gene and biological therapies Sciad Newswire
24-Aug-2022 Dry Powder Inhaler Market is set to experience a significant growth of 4.6% CAGR during forecast period by 2031 MARKITWIRED
24-Aug-2022 Neonatal Thermoregulation Market Comprehensive Shares, Historical Trends And Forecast By 2031 MARKITWIRED
24-Aug-2022 AEVIS VICTORIA SA – AEVS.SW: Revenues up by 42.6% to CHF 584.2 million (2021: CHF 409.8 million) in the first semester of 2022 AEVIS VICTORIA SA
24-Aug-2022 Relief Therapeutics files registration statement on form F-1 with the U.S. Securities and Exchange Commission Relief Therapeutics Holding SA
23-Aug-2022 Beckman Coulter Life Sciences Partners with Flownamics on Bioprocess Culture Monitoring Solution Beckman Coulter Life Sciences
23-Aug-2022 Chesterford Research Park welcomes ambitious new biotech firm Chesterford Research Park
23-Aug-2022 NHS delivering on tech inclusion according to new research Gemserv
23-Aug-2022 President Special Public Communications
23-Aug-2022 £10.4m full-service contract signed with existing Big Pharma client Open Orphan plc
23-Aug-2022 HUTCHMED Highlights Fruquintinib MRCT FRESCO-2 Data to be Presented at the Upcoming ESMO Congress 2022 HUTCHMED
23-Aug-2022 BioInnovation Institute announces new Venture House program and initial intake of four innovative companies BioInnovation Institute
23-Aug-2022 Innovative Attosecond Optics from Edmund Optics® and UltraFast Innovations Awarded Platinum-Level 2022 LFW Innovators Award! Ultrafast Innovations GmbH
23-Aug-2022 The health and social work sector offers the fourth best employer pension contributions of any industry Investing Reviews
23-Aug-2022 CSL Vifor and Travere Therapeutics announce EMA has accepted for review the Conditional Marketing Authorization application for sparsentan for the treatment of IgA Nephropathy CSL Vifor
23-Aug-2022 ISCT marks bluebird bio’s landmark FDA approval a celebration for the CGT sector while calling industry to attention in the pursuit of patient access ISCT
23-Aug-2022 Bristol Myers Squibb UK&I is first pharmaceutical company to be accredited as a Menopause Friendly Workplace Bristol Myers Squibb UK&I
23-Aug-2022 The BioInnovation Institute supports three international start-ups developing pioneering science in the therapeutics and health tech space The BioInnovation Institute